Cerebral folate deficiency: life-changing supplementation with folinic acid

Mol Genet Metab. 2005 Apr;84(4):371-3. doi: 10.1016/j.ymgme.2004.12.001. Epub 2005 Jan 22.

Abstract

Cerebral folate deficiency is characterized by low cerebrospinal fluid (CSF) concentrations of 5-methyltetrahydrofolate and a broad spectrum of clinical signs and symptoms. A patient with progressive spasticity, gait disturbance, speech difficulties, initially diagnosed as a recessive spastic paraplegia recovered on folinic acid (15-30 mg/day) and her 5-methyltetrahydrofolate in CSF normalized. This report demonstrates the importance of CSF investigation in the diagnosis of cerebral folate deficiency and efficiency of folinic acid (5-formyltetrahydrofolate) supplementation.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain Diseases / cerebrospinal fluid
  • Brain Diseases / diagnosis*
  • Brain Diseases / drug therapy*
  • Child
  • Child, Preschool
  • Dietary Supplements
  • Dose-Response Relationship, Drug
  • Female
  • Folic Acid Deficiency / cerebrospinal fluid
  • Folic Acid Deficiency / diagnosis*
  • Folic Acid Deficiency / drug therapy*
  • Gait
  • Humans
  • Leucovorin / therapeutic use*
  • Life Style
  • Movement Disorders / drug therapy
  • Paraplegia / diagnosis
  • Paraplegia / etiology
  • Pregnancy
  • Speech Disorders / drug therapy
  • Tetrahydrofolates / cerebrospinal fluid

Substances

  • Tetrahydrofolates
  • Leucovorin
  • 5-methyltetrahydrofolate